Browse studies

Find your next paid study

25,415 recruiting studies available now

Natural History and Biospecimen Acquisition Study for Children and Adults With Rare Solid Tumors

Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small p…

Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid Tumor+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT03739827

Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Study Description: This study examines relations between neurocognitive and clinical features of pediatric anxiety disorders. The study uses neuro-cognitive t…

Anxiety DisordersMajor Depressive Disorder

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Mental Health (NIMH)NCT00018057

Natural History Study of Children and Adults With Chordoma

Background: Chordoma is a rare type of bone cancer. It occurs in the skull base or spine. Researchers want to study people with chordoma in different ways. Th…

Chordoma

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT03910465

Observational

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when…

DiabetesEnd Stage Renal Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Sonavex, Inc.NCT06190717

Phase 3

An Open-Label, Randomized, Multicenter Phase 3 Study Investigating the Efficacy and Safety of BGB-43395 Plus Letrozole Versus CDK4/6 Inhibitors (Abemaciclib, Palbociclib, Ribociclib) Plus Letrozole in Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Systemic Anticancer Treatment for Advanced or Metastatic Disease

The purpose of this study is to investigate the efficacy and safety of BGB-43395 in combination with letrozole compared with investigator's choice of cyclin-de…

HR+/HER2- Breast Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

BeOne MedicinesNCT07492641

Observational

Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors

This is a two-arm randomized controlled trial (RCT) to determine the feasibility of a larger, fully powered trial in younger ER+ BCS undergoing endocrine thera…

Breast Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07501637

Phase 2

KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and lung c…

Non-small Cell Lung Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06731907

Phase 1

A Phase 0/I/II Study of the Cyclin-Dependent Kinase(CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas

Background: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical proble…

Neurofibromatosis 1

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04750928

Starting Treatment at Time Zero With Ocrevus Zunovo (STAT Ocrevus Zunovo)

This study will compare starting Ocrevus Zunovo soon after an active episode of relapsing multiple sclerosis (MS) with starting it later. Researchers want to l…

Relapse Remitting Multiple Sclerosis

Estimated

~$10 – $750

Actual pay is set by the research site.

Oklahoma Medical Research FoundationNCT07878923

The Rutgers University Genetics Coordinating Center Breast Cancer Study

The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a …

Breast Cancer RiskBreast Cancer PreventionBreast Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Rutgers, The State University of New JerseyNCT06773897

Phase 1

Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Background: B-cell lymphoma is a cancer of white blood cells found in the lymph nodes. It affects the system that fights infections and disease. Researchers w…

LymphomaNon-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma+1 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT03223610

Studies of the Natural History of Rheumatic Diseases

This study will explore the causes of rheumatic diseases and why many of them affect certain minority communities more severely. Rheumatic diseases may cause j…

Rheumatic DiseasesArthritis

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT00024479